SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001144204-07-007687
Filing Date
2007-02-14
Accepted
2007-02-14 12:23:48
Documents
4
Group Members
D. E. SHAW & CO., L.L.C.D. E. SHAW & CO., L.P.DAVID E. SHAW

Document Format Files

Seq Description Document Type Size
1 v064578_sc13g-a.htm SC 13G/A 165956
2 v064578_ex1.htm EX-1 7911
3 v064578_ex2.htm EX-2 7977
4 v064578_ex3.htm EX-3 15973
  Complete submission text file 0001144204-07-007687.txt   199815
Mailing Address
Business Address 1450 INFINITE DRIVE LOUISVILLE CO 80027 303-665-3450
REPLIDYNE INC (Subject) CIK: 0001180145 (see all company filings)

IRS No.: 000000000
Type: SC 13G/A | Act: 34 | File No.: 005-81890 | Film No.: 07616463
SIC: 2834 Pharmaceutical Preparations

Mailing Address 39TH FLOOR, TOWER 45 120 WEST FORTY-FIFTH STREET NEW YORK NY 10036
Business Address 39TH FLOOR, TOWER 45 120 WEST FORTY-FIFTH STREET NEW YORK NY 10036 212-478-0000
D. E. Shaw Meniscus Portfolios, L.L.C. (Filed by) CIK: 0001324348 (see all company filings)

IRS No.: 510481096 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A